JERAYGO

Serial Number 97159382
734

Registration Progress

Application Filed
Dec 7, 2021
Under Examination
Dec 20, 2022
Approved for Publication
Oct 25, 2022
Published for Opposition
Oct 25, 2022
Registered

Attorney Assistance

NOA E-Mailed - SOU Required
Due: Dec 20, 2025 2 days
Statement of Use required (all extensions used)

Trademark Image

JERAYGO

Basic Information

Serial Number
97159382
Filing Date
December 7, 2021
Published for Opposition
October 25, 2022
Drawing Code
4

Status Summary

Current Status
Active
Status Code
734
Status Date
Dec 8, 2025
Application
Pending
Classes
005

Rights Holder

IDORSIA PHARMACEUTICALS LTD

25
Address
HEGENHEIMERMATTWEG 91
ALLSCHWIL CH-4123
CH

Ownership History

JOHNSON & JOHNSON

Original Applicant
03
New Brunswick, NJ

JOHNSON & JOHNSON

Owner at Publication
03
New Brunswick, NJ

IDORSIA PHARMACEUTICALS LTD

New Owner After Publication #1
25
ALLSCHWIL CH

Legal Representation

Attorney
Mary Margaret L. O'Donnell

USPTO Deadlines

Next Deadline
2 days remaining
NOA E-Mailed - SOU Required
Due Date
December 20, 2025

Application History

35 events
Date Code Type Description Documents
Dec 9, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 8, 2025 EX5G S SOU EXTENSION 5 GRANTED Loading...
Jun 13, 2025 EXT5 S SOU EXTENSION 5 FILED Loading...
Dec 8, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jun 13, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 3, 2024 EX4G S SOU EXTENSION 4 GRANTED Loading...
Dec 3, 2024 EXT4 S SOU EXTENSION 4 FILED Loading...
Dec 3, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Jun 12, 2024 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 12, 2024 EX3G S SOU EXTENSION 3 GRANTED Loading...
Jun 12, 2024 EXT3 S SOU EXTENSION 3 FILED Loading...
Jun 12, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 22, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Dec 20, 2023 EX2G S SOU EXTENSION 2 GRANTED Loading...
Dec 20, 2023 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 20, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 20, 2023 ASCK I ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY Loading...
Dec 19, 2023 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Dec 19, 2023 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Dec 19, 2023 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Dec 19, 2023 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Dec 19, 2023 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jun 14, 2023 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 12, 2023 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 12, 2023 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 12, 2023 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 20, 2022 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Oct 25, 2022 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Oct 25, 2022 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 5, 2022 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 16, 2022 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 12, 2022 DOCK D ASSIGNED TO EXAMINER Loading...
Dec 13, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Dec 10, 2021 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

Classification

International Classes
005